MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1272/jnms.81.364

Медицинская библиотека · Journal of Nippon Medical School = Nippon Ika Daigaku zasshi · 2014

Serum KL-6 elevation and possible pulmonary involvement in patients with rheumatoid arthritis treated with biological agents.

Takahashi Kenji, Nakamura Hiroshi, Takenouchi Kenji, Iizawa Norishige, Koiwa Masahito, Sato Akiko, Mochizuki Yusuke, Watanabe Hiroshi, Takai Shinro

СтатьяПеревод в очереди

Аннотация

BACKGROUNDS: Interstitial lung disease (ILD) is associated with rheumatoid arthritis (RA) itself and is also induced by biological and non-biological disease-modifying antirheumatic drugs. The glycoprotein Krebs von den Lungen-6 (KL-6) is reported to be a marker for the activity of ILD.

OBJECTIVES

To elucidate the relationship between serum KL-6 levels in patients with RA treated with biological agents and pulmonary involvement on computed tomography of the chest.

METHODS

The subjects were 307 patients with RA treated with infliximab, etanercept, adalimumab, or tocilizumab. Medical records were reviewed to investigate serum KL-6 levels, disease activity, and pulmonary imaging findings.

RESULTS

Levels of KL-6 were abnormally elevated in 25 patients (8.1%): 15 patients (11.2%) treated with infliximab, 6 patients (4.4%) treated with etanercept, and 4 patients (22.2%) treated with adalimumab, but in no patients treated with tocilizumab. However, no clinical pulmonary events developed. Computed tomography of the chest showed the start or progression of interstitial fibrotic change in 5 of 25 (20%) patients with abnormal KL-6 values. The changes in disease activity did not differ significantly between patients who showed elevated KL-6 values and those who did not.

CONCLUSIONS

Serum KL-6 levels were elevated in 8.1% of patients with RA treated with biological agents. Careful observation is necessary for these patients regarding lung fibrosis.

Для цитирования: Takahashi Kenji, Nakamura Hiroshi, Takenouchi Kenji, Iizawa Norishige, Koiwa Masahito, Sato Akiko, Mochizuki Yusuke, Watanabe Hiroshi, Takai Shinro. Serum KL-6 elevation and possible pulmonary involvement in patients with rheumatoid arthritis treated with biological agents.. Journal of Nippon Medical School = Nippon Ika Daigaku zasshi. 2014. DOI: 10.1272/jnms.81.364.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.